You are required to be logged in to access the full website
Click here if you have forgotten your username or password
23 June 2026 - Clinical-stage biotechnology company Enanta Pharmaceuticals Inc (NASDAQ:ENTA) announced on Tuesday that its partner AbbVie (NYSE:ABBV) has received European Commission approval for MAVIRET (glecaprevir/pibrentasvir) to treat acute hepa...
23 June 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) reported on Tuesday that the European Commission has approved Cenrifki (tolebrutinib) for the treatment of secondary progressive multiple sclerosis (SPMS) without ...
23 June 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) announced on Tuesday that Japan's Ministry of Health, Labour and Welfare has granted marketing and manufacturing authorisation for Wayrilz (rilzabrutinib), an...
23 June 2026 - US pharmaceutical company Eli Lilly and Company (NYSE:LLY) announced on Monday that its board of directors has declared a dividend of USD1.73 per share of common stock for the third quarter of 2026.This amount is unchanged from the pre...
23 June 2026 - Nura Bio Inc, a clinical-stage biopharmaceutical company developing neuroprotective small molecule therapies, announced on Monday that it has completed a USD73.8m Series B financing. The company also reported progress in its two clinic...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe